Literature DB >> 17482260

The effect of covalently immobilized rhIL-1ra-ELP fusion protein on the inflammatory profile of LPS-stimulated human monocytes.

Dong-Hwan Kim1, Jason T Smith, Ashutosh Chilkoti, William M Reichert.   

Abstract

The objective of this research was to investigate whether immobilized anti-inflammatory cytokines will signal changes in the inflammatory profile of cultured monocytes. A fusion protein of recombinant human IL-1 receptor antagonist and elastin-like peptide (IL-1ra-ELP) was expressed in Escherichia coli. THP-1 human monocytes were cultured on either carboxyl-terminated self-assembled monolayers (SAMs), or SAMs with either covalently immobilized or soluble IL-1ra-ELP. LPS-stimulated monocytes exposed to either soluble or immobilized IL-1ra-ELP were prevented from cell differentiation, showed attenuated expression of pro-inflammatory cytokines, and had increased production of anti-inflammatory and pro-wound healing cytokines. These results suggest that immobilized anti-inflammatory cytokines have the potential to be immunomodulatory biomaterials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482260      PMCID: PMC2680615          DOI: 10.1016/j.biomaterials.2007.04.010

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  41 in total

1.  Purification of recombinant proteins by fusion with thermally-responsive polypeptides.

Authors:  D E Meyer; A Chilkoti
Journal:  Nat Biotechnol       Date:  1999-11       Impact factor: 54.908

2.  Cytokine traps: multi-component, high-affinity blockers of cytokine action.

Authors:  Aris N Economides; Laura Rocco Carpenter; John S Rudge; Vivien Wong; Ellen M Koehler-Stec; Christopher Hartnett; Erica A Pyles; Xiaobing Xu; Thomas J Daly; Michael R Young; James P Fandl; Frank Lee; Scott Carver; Jennifer McNay; Kevin Bailey; Swayampakula Ramakanth; Renta Hutabarat; Tammy T Huang; Czeslaw Radziejewski; George D Yancopoulos; Neil Stahl
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

3.  Engineering growing tissues.

Authors:  Eben Alsberg; Kenneth W Anderson; Amru Albeiruti; Jon A Rowley; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

4.  Fast transient cytokine-receptor interactions monitored in real time by reflectometric interference spectroscopy.

Authors:  J Piehler; G Schreiber
Journal:  Anal Biochem       Date:  2001-02-15       Impact factor: 3.365

Review 5.  Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease.

Authors:  F Cominelli; T T Pizarro
Journal:  Aliment Pharmacol Ther       Date:  1996       Impact factor: 8.171

6.  Ligand binding analysis of soluble interleukin-2 receptor complexes by surface plasmon resonance.

Authors:  Z Wu; K W Johnson; Y Choi; T L Ciardelli
Journal:  J Biol Chem       Date:  1995-07-07       Impact factor: 5.157

7.  Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells.

Authors:  B K Mann; R H Schmedlen; J L West
Journal:  Biomaterials       Date:  2001-03       Impact factor: 12.479

8.  Effects of recombinant soluble type I interleukin-1 receptor on human inflammatory responses to endotoxin.

Authors:  H L Preas; D Reda; M Tropea; R W Vandivier; S M Banks; J M Agosti; A F Suffredini
Journal:  Blood       Date:  1996-10-01       Impact factor: 22.113

9.  Cytokines in symptomatic asthma airways.

Authors:  D H Broide; M Lotz; A J Cuomo; D A Coburn; E C Federman; S I Wasserman
Journal:  J Allergy Clin Immunol       Date:  1992-05       Impact factor: 10.793

10.  IL-1ra suppresses endotoxin-induced IL-1 beta and TNF-alpha release from mononuclear phagocytes.

Authors:  C B Marsh; S A Moore; H A Pope; M D Wewers
Journal:  Am J Physiol       Date:  1994-07
View more
  20 in total

1.  Elastomeric polypeptide-based biomaterials.

Authors:  Linqing Li; Manoj B Charati; Kristi L Kiick
Journal:  J Polym Sci A Polym Chem       Date:  2010-10       Impact factor: 2.702

2.  Short-term and long-term effects of orthopedic biodegradable implants.

Authors:  Ami R Amini; James S Wallace; Syam P Nukavarapu
Journal:  J Long Term Eff Med Implants       Date:  2011

3.  Fusion order controls expression level and activity of elastin-like polypeptide fusion proteins.

Authors:  Trine Christensen; Miriam Amiram; Sue Dagher; Kimberly Trabbic-Carlson; Mohammed F Shamji; Lori A Setton; Ashutosh Chilkoti
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

4.  Anti-inflammatory polymeric coatings for implantable biomaterials and devices.

Authors:  Amanda W Bridges; Andrés J García
Journal:  J Diabetes Sci Technol       Date:  2008-11

Review 5.  Protein based therapeutic delivery agents: Contemporary developments and challenges.

Authors:  Liming Yin; Carlo Yuvienco; Jin Kim Montclare
Journal:  Biomaterials       Date:  2017-04-21       Impact factor: 12.479

Review 6.  IL-1Ra and its delivery strategies: inserting the association in perspective.

Authors:  Muhammad Sajid Hamid Akash; Kanwal Rehman; Shuqing Chen
Journal:  Pharm Res       Date:  2013-06-22       Impact factor: 4.200

7.  Sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolongs its therapeutic potentials.

Authors:  Muhammad Sajid Hamid Akash; Kanwal Rehman; Ni Li; Jian-Qing Gao; Hongying Sun; Shuqing Chen
Journal:  Pharm Res       Date:  2012-08-21       Impact factor: 4.200

Review 8.  Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials.

Authors:  Matthew T Novak; James D Bryers; William M Reichert
Journal:  Biomaterials       Date:  2009-01-29       Impact factor: 12.479

9.  Materials that harness and modulate the immune system.

Authors:  Jamal S Lewis; Krishnendu Roy; Benjamin G Keselowsky
Journal:  MRS Bull       Date:  2014-01-01       Impact factor: 6.578

10.  In vivo cytokine-associated responses to biomaterials.

Authors:  Robert J Schutte; Lola Xie; Bruce Klitzman; William M Reichert
Journal:  Biomaterials       Date:  2008-10-11       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.